CD276 and neuroblastoma: Importantly, in Wilms tumor, B7-H3 expression was identified in 100% of stained specimens, of which 67% were highly positive, pinpointing B7-H3 as a therapeutic target in pediatric malignancies beyond neuroblastoma [154].